InvestorsHub Logo
Followers 57
Posts 11397
Boards Moderated 0
Alias Born 02/09/2009

Re: None

Tuesday, 05/19/2015 11:57:36 AM

Tuesday, May 19, 2015 11:57:36 AM

Post# of 30990
$31 million upfront for anti-inflammatory after phase 1

http://www.biospectrumasia.com/biospectrum/news/221289/boehringer-ingelheim-acquires-pharmaxis-anti-inflammatory-drug-candidate/page/1

This payment was for the drug only, not for the company. Further payments will be made based on further success.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.